Oncoclínicas do Brasil Serviços Médicos: Revenue and margins fell in Q1 2026 due to medication shortages and higher provisions

About this update from Oncoclinicas Do Brasil Servicos Medicos Sa

Q1 2026 saw operational and financial pressures, with revenue hit by medication shortages and a one-time spike in doubtful accounts provisioning. Cost controls and capital discipline are underway, but leverage increased and cash flow was negative.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Oncoclinicas Do Brasil Servicos Medicos Sa